FirmaIQ
Org.nr 991 729 666 2021 → 2022 Year-over-year analysis

ABBOTT MEDICAL NORWAY AS: årsregnskap 2022 vs 2021

Grew 91518% on revenue

approved 2023-06-29; registry 2023-07-20; journal 2023 595765

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2022 with 2021 for ABBOTT MEDICAL NORWAY AS. Revenue 153.1k NOK → 140.29m NOK (+91517.6%). Net result +3.57m NOK → +3.17m NOK. Equity 21.64m NOK → 24.81m NOK.

On the constructive side: revenue rose; equity strengthened; cash rose. Pressures included: operating result weakened; net result weakened.

Also worth watching: headcount (årsverk) changed. All figures are taken from the published annual accounts for ABBOTT MEDICAL NORWAY AS.

At a glance

Scorecard

Revenue
153.1k NOK 140.29m NOK
+91517.6%
Operating result
+4.79m NOK +4.10m NOK
-14.4%
Net result
+3.57m NOK +3.17m NOK
-11.4%
Equity
21.64m NOK 24.81m NOK
+14.6%
Cash
11.05m NOK 12.02m NOK
+8.8%
Total assets
58.21m NOK 57.51m NOK
-1.2%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 153.1k NOK to 140.29m NOK (+91517.6% YoY). Calculated

  • ↑

    Equity strengthened

    Book equity 21.64m NOK → 24.81m NOK (equity ratio 37.2% → 43.1%). Calculated

  • ↑

    Cash rose

    Bank deposits 11.05m NOK → 12.02m NOK (+8.8% YoY). Calculated

What deteriorated

  • ↓

    Operating result weakened

    Operating result +4.79m NOK → +4.10m NOK (op. margin 3127.4% → 2.9%). Calculated

  • ↓

    Net result weakened

    Net result +3.57m NOK → +3.17m NOK (net margin 2333.3% → 2.3%). Calculated

Things to notice

  • ·

    Headcount (årsverk) changed

    Reported FTEs 15 → 16. Reported fact